Net Cash Provided by (Used in) Operating Activities |
-2M |
USD |
+61.8% |
Q1 2025 |
Q1 2025 |
Net Cash Provided by (Used in) Financing Activities |
2.87M |
USD |
-44.9% |
Q1 2025 |
Q1 2025 |
Net Cash Provided by (Used in) Investing Activities |
-4.58K |
USD |
+87.4% |
Q1 2024 |
Q1 2025 |
Common Stock, Shares Authorized |
250M |
shares |
0% |
Q2 2025 |
Q2 2025 |
Common Stock, Shares, Issued |
1.01M |
shares |
-95.6% |
Q2 2025 |
Q2 2025 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2025 |
Q2 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
931K |
USD |
|
Q1 2025 |
Q1 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
284K |
USD |
-69.5% |
Q2 2025 |
Q2 2025 |
Deferred Tax Assets, Valuation Allowance |
20.4M |
USD |
+30.2% |
Q4 2024 |
FY 2024 |
Deferred Tax Assets, Gross |
20.5M |
USD |
+20.4% |
Q4 2024 |
FY 2024 |
Depreciation |
1.7K |
USD |
+30.6% |
Q1 2023 |
Q1 2023 |
Payments to Acquire Property, Plant, and Equipment |
4.58K |
USD |
+152% |
Q1 2024 |
Q1 2025 |
Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
-42.2M |
USD |
+24% |
Q2 2025 |
Q2 2025 |
Operating Lease, Liability, Current |
21.4K |
USD |
-82.1% |
Q2 2025 |
Q2 2025 |
Deferred Income Tax Expense (Benefit) |
-122K |
USD |
|
Q1 2024 |
Q1 2025 |
Deferred Tax Assets, Operating Loss Carryforwards |
13.3M |
USD |
+30.3% |
Q4 2024 |
FY 2024 |
Preferred Stock, Shares Issued |
0 |
shares |
|
Q3 2023 |
Q3 2023 |
Current Income Tax Expense (Benefit) |
51K |
USD |
|
Q2 2024 |
Q2 2025 |
Preferred Stock, Shares Authorized |
10M |
shares |
|
Q2 2025 |
Q2 2025 |
Unrecognized Tax Benefits |
26.5K |
USD |
+55.6% |
Q4 2024 |
FY 2024 |
Additional Paid in Capital |
135M |
USD |
+173% |
Q2 2025 |
Q2 2025 |
Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q1 2024 |
Q1 2024 |
Amortization of Intangible Assets |
198K |
USD |
|
Q3 2024 |
Q3 2024 |
Depreciation, Depletion and Amortization |
207K |
USD |
+12073% |
Q1 2024 |
Q1 2024 |
Deferred Tax Assets, Net of Valuation Allowance |
25.1K |
USD |
-98.1% |
Q4 2024 |
FY 2024 |
Share-based Payment Arrangement, Expense |
447K |
USD |
|
Q2 2025 |
Q2 2025 |
Interest Expense |
269K |
USD |
|
Q3 2023 |
Q3 2023 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
|
Q2 2025 |
Q2 2025 |